CDKN2C and cancer: However, we believe that the mechanisms of CDKN2C expression in cancer (including SCLC) transcend its role in these signaling pathways because our pan-cancer analysis revealed that upregulated CDKN2C expression demonstrated poor prognosis in most cancers, including SCLC.